- Joint publication of virologists in the peer-reviewed journal Nutraceuticals demonstrates effectiveness of iota-carrageenan (Carragelose) against SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.5
- Results demonstrate superiority of iota-carrageenan compared to other virus-blocking carrageenans in inhibiting the replication of a wide range of respiratory viruses
- Protective barrier provided by iota-carrageenan is applicable as safe prophylaxis and early treatment of viral respiratory infections and might help fight future pandemics
The full press release is available as download here: